Cohen & Steers Inc. decreased its holdings in Cigna Corporation (NYSE:CI) by 38.6% in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 102,435 shares of the health services provider’s stock after selling 64,450 shares during the quarter. Cohen & Steers Inc.’s holdings in Cigna were worth $19,149,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also bought and sold shares of the company. Saratoga Research & Investment Management purchased a new position in Cigna in the third quarter worth approximately $112,000. Capstone Investment Advisors Netherlands B.V. purchased a new position in Cigna in the second quarter worth approximately $106,000. Horan Capital Advisors LLC. purchased a new position in Cigna in the third quarter worth approximately $123,000. Parallel Advisors LLC lifted its stake in Cigna by 62.3% in the second quarter. Parallel Advisors LLC now owns 800 shares of the health services provider’s stock worth $139,000 after acquiring an additional 307 shares during the last quarter. Finally, Grove Bank & Trust lifted its stake in Cigna by 171.9% in the third quarter. Grove Bank & Trust now owns 976 shares of the health services provider’s stock worth $182,000 after acquiring an additional 617 shares during the last quarter. 87.85% of the stock is owned by institutional investors and hedge funds.
A number of research analysts recently issued reports on the stock. Citigroup lifted their price target on shares of Cigna from $198.00 to $231.00 and gave the stock a “buy” rating in a research note on Friday, November 3rd. Morgan Stanley raised their price objective on shares of Cigna from $195.00 to $223.00 and gave the stock an “overweight” rating in a report on Friday, November 3rd. Jefferies Group raised their price objective on shares of Cigna from $221.00 to $231.00 and gave the stock a “buy” rating in a report on Friday, November 3rd. Royal Bank Of Canada reissued an “outperform” rating and set a $220.00 price objective (up previously from $185.00) on shares of Cigna in a report on Friday, November 3rd. Finally, Zacks Investment Research cut shares of Cigna from a “buy” rating to a “hold” rating in a report on Friday, November 10th. Three research analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has given a strong buy rating to the stock. The stock has a consensus rating of “Buy” and an average price target of $201.50.
In other Cigna news, insider Christopher J. Hocevar sold 8,387 shares of the business’s stock in a transaction on Monday, November 27th. The shares were sold at an average price of $200.32, for a total transaction of $1,680,083.84. Following the sale, the insider now directly owns 12,363 shares in the company, valued at approximately $2,476,556.16. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Michael W. Triplett sold 10,417 shares of the business’s stock in a transaction on Monday, November 13th. The stock was sold at an average price of $197.77, for a total transaction of $2,060,170.09. Following the sale, the insider now owns 32,347 shares in the company, valued at $6,397,266.19. The disclosure for this sale can be found here. Over the last quarter, insiders sold 36,203 shares of company stock worth $7,211,251. 1.30% of the stock is currently owned by insiders.
Cigna Corporation (NYSE CI) opened at $209.97 on Friday. The company has a market cap of $51,768.11, a price-to-earnings ratio of 20.23, a PEG ratio of 1.60 and a beta of 0.50. Cigna Corporation has a 1-year low of $131.03 and a 1-year high of $212.46. The company has a debt-to-equity ratio of 0.37, a current ratio of 0.39 and a quick ratio of 0.39.
Cigna (NYSE:CI) last announced its earnings results on Thursday, November 2nd. The health services provider reported $2.83 EPS for the quarter, beating analysts’ consensus estimates of $2.36 by $0.47. Cigna had a net margin of 5.74% and a return on equity of 18.85%. The business had revenue of $10.38 billion for the quarter, compared to analysts’ expectations of $10.17 billion. During the same period in the previous year, the company posted $1.94 EPS. The company’s quarterly revenue was up 5.1% on a year-over-year basis. analysts predict that Cigna Corporation will post 10.34 earnings per share for the current fiscal year.
COPYRIGHT VIOLATION WARNING: “Cigna Corporation (CI) Shares Sold by Cohen & Steers Inc.” was published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this story on another domain, it was copied illegally and republished in violation of United States and international copyright laws. The legal version of this story can be viewed at https://www.dispatchtribunal.com/2017/12/10/cigna-corporation-ci-shares-sold-by-cohen-steers-inc.html.
Cigna Company Profile
Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.
Receive News & Ratings for Cigna Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Corporation and related companies with MarketBeat.com's FREE daily email newsletter.